Jonathan Z. Li, MD, MMSc

Associate Professor of Medicine
Brigham and Women's Hospital
Boston, MA, United States

Dr. Li is an Associate Professor of Medicine at the Brigham and Women’s Hospital and Harvard Medical School. He leads an active clinical and translational laboratory research program focused on viral persistence, reservoirs and resistance, especially within the fields of HIV and COVID-19. Dr. Li is the Director of the Harvard/Brigham Virology Specialty Laboratory, the Director of the Harvard University Center for AIDS Research Clinical Core, and a member of the NIH COVID-19 Treatment Guidelines Panel. He is the protocol co-Chair of several AIDS Clinical Trials Group studies, and the protocol virologist for the ACTIV-2 Adaptive Platform Treatment Trial for Outpatients with COVID-19. He will be the incoming Deputy Editor for the Journal of Infectious Diseases.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 878 - Association between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death for Non-Hospitalized Adults with Mild-to-Moderate COVID-19

  Friday, October 21, 2022
  10:30 AM – 10:45 AM US ET

• 881 - Nasal and Plasma SARS-CoV-2 RNA Levels Predict Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19

  Friday, October 21, 2022
  11:15 AM – 11:30 AM US ET

• 178 - Acute HIV Update: Diagnosis, Treatment and Viral Reservoir

  Friday, October 21, 2022
  3:15 PM – 4:30 PM US ET